This article reviews evidence for RASI therapy in patients with advanced CKD, with the aim of enhancing GPs’ awareness to the cardiovascular and renoprotective benefits.

General Practice Liaison staff undertake a range of activities to improve information flow, care processes and capacity across both sectors.

This study provides insights into the management of heavy menstrual bleeding (HMB) prior to the release of the HMB clinical care standard.

Healthcare providers value nutrition care, yet are limited by the healthcare system to provide comprehensive care to people with prediabetes.

Transgender people may seek healthcare for reasons unrelated to gender, but they are often negatively impacted by structural and interpersonal discrimination in health settings.

Evidence supports some beneficial effects of antibiotics prescribed to patients with a sore throat and proven presence of group A streptococci.

Complex spinal pain interdisciplinary assessment in a primary care setting shows reasonable long-term outcomes comparable to more intensive interventions.

Skin lesions may provide a clue to diagnosis in a patient with persistent fever and history of recent travel.

A man aged 60 years presented with an irregularly shaped erythematous scalp plaque with a 5 cm diameter.

There is a need to enhance aged care exposure for general practice registrars in ways that build on the competence of registrars and the trust in registrars by older patients and supervisors.

General practitioners are well positioned to take a comprehensive approach to the management of functional decline in older people, aided by a range of funded programs.

Young people experience higher rates of sexually transmissible infections and lower screening rates than the general population in Australia.

How should GPs and patients prioritise which preventive health activities to undertake?

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.

For the detection of early COVID-19 disease, RCPA supports the use of molecular tests for SARS-CoV-2 and strongly opposes the introduction of COVID-19 IgG/IgM rapid tests for this purpose.